Publications
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials2021 | Second Faculty of Medicine, First Faculty of Medicine
- CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein2021 | Second Faculty of Medicine
- The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients2020 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge2020 | Second Faculty of Medicine
- The potential role of neutrophil trogocytosis and G-CSF in the loss of HER2 expression2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- The relevance of Fas/Fas ligand axis in the tumor microenvironment of salivary gland adenoid cystic carcinoma2019 | Second Faculty of Medicine, First Faculty of Medicine
- The WNT/beta-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro2019 | Second Faculty of Medicine
Loading network view...